Vaquero Javier, Blei Andres T
Department of Medicine, Northwestern Feinberg Medical School, Searle 10-573, 303 East Chicago Avenue, Chicago, IL 60611, USA.
Curr Gastroenterol Rep. 2003 Feb;5(1):39-47. doi: 10.1007/s11894-003-0008-8.
Fulminant hepatic failure (FHF) remains a rare but devastating disease. Viruses and drug-induced hepatotoxicity are the most common causes of the syndrome, but the relevance of each differs depending on the geographic area. In a large proportion of patients no cause for FHF can be identified. Good intensive care is critical for patient survival. Orthotopic liver transplantation (OLT) remains a definitive therapeutic option. Prognostic indices have helped to optimize patient selection and timing for performance of OLT. However, the accuracy of these prognostic indices decreases when they are applied to different populations, probably because of regional differences in etiology and peculiar native host factors. More accurate prognostic criteria and new therapeutic alternatives to OLT are required.
暴发性肝衰竭(FHF)仍然是一种罕见但极具破坏性的疾病。病毒和药物性肝毒性是该综合征最常见的病因,但每种病因的相关性因地理区域而异。在很大一部分患者中,无法确定FHF的病因。良好的重症监护对患者生存至关重要。原位肝移植(OLT)仍然是一种确定性的治疗选择。预后指标有助于优化OLT的患者选择和实施时机。然而,当将这些预后指标应用于不同人群时,其准确性会降低,这可能是由于病因的区域差异和独特的宿主因素所致。需要更准确的预后标准和OLT的新治疗替代方案。